Showing 1841-1850 of 3475 results for "".
Is a Good Faith Estimate Required for a Filler or Neuromodulator Treatment?
https://practicaldermatology.com/topics/practice-management/is-a-good-faith-estimate-required-for-a-filler-or-neuromodulator-treatment/23852/The latest updates from CMS do not specifically mention aesthetics in reference to good faith estimates, but there are indications that some aesthetic and dermatology services will require them. What about an appointment for injectables?Positive Energy
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/positive-energy/23850/Energy-based devices offer cosmetic patients visible results with minimal downtime.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-42/23844/A Dermatologist’s Guide to LinkedIn Marketing
https://practicaldermatology.com/topics/practice-management/a-dermatologists-guide-to-linkedin-marketing/23830/Understanding unique features of the social network allows practices to optimize their brand engagement.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-40/23808/DermWireTV: Diversity in Dermatology; Inclusive Beauty Initiatives; Eczema Awareness Month
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-diversity-in-dermatology-inclusive-beauty-initiatives-eczema-awareness-month/20152/La Roche-Posay and the Women's Dermatologic Society have partnered to sponsor a Fellowship in the Department of Dermatology at Howard University's College of Medicine for Underrepresented in medicine medical students. WDS President Mona Gohara, MD shares insights about the need to support DEDermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologyNew in My Practice: Devices/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-devicesnew-products-1/23772/Special Report: Dermatology Industry Responds to Inequities in Care
https://practicaldermatology.com/topics/skin-of-color/special-report-dermatology-industry-responds-to-inequities-in-care/23765/Finding Influencers to Promote Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/finding-influencers-to-promote-your-dermatology-practice/23757/Influencer marketing is not simply a form of paid advertisement; it is based on a mutually beneficial partnership.